SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Q2 2024 Earnings Call Transcript

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Q2 2024 Earnings Call Transcript August 7, 2024

Samantha Sandler – Senior Director of IR:

Saqib Islam – CEO:

A closeup of a scientist in a lab coat, mixing two liquids for a compound to treat rare diseases.

Bhavesh Ashar – Chief Commercial Officer:

Jim Cassidy – CMO:

Frank Perier – CFO:

Q&A Session

Follow Southwall Technologies Inc (NASDAQ:SWTX)